Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aqtual
AddedFeb 15, 2024
UpdatedJun 18, 2026
Aqtual

Aqtual

Aqtual: A Hayward-based software company offering biotech diagnostic and healthcare solutions.

HQ
Hayward, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded in Hayward, California, Aqtual is a biotechnology diagnostics platform focused on revolutionizing chronic disease and oncology management. The company's core mission is to bridge the translational gap between groundbreaking research and practical healthcare solutions. Aqtual offers advanced diagnostic tools and healthcare solutions, leveraging proprietary biochemistry, novel technology, and data science to address some of the costliest disease areas, including rheumatoid arthritis.

Aqtual has garnered attention for its innovative approach to precision medicine, with a team of experts in biochemistry and technology driving its mission forward. The company has made significant strides in developing a comprehensive catalog of disease-specific diagnostics. Notable achievements include partnerships with leading healthcare institutions and recognition in scientific publications. Aqtual's impact lies in its potential to transform chronic disease management, making cutting-edge research accessible and actionable in clinical settings.

Aqtual - Similar Companies

AQH logo

AQH

Exactus logo

Exactus

Ariel Precision Medicine logo

Ariel Precision Medicine

arielmedicine.com

AIQ Solutions logo

AIQ Solutions

aiq-solutions.com

ActivSignal logo

ActivSignal

activsignal.com

Akili Labs logo

Akili Labs

Drift Bio logo

Drift Bio

Aegirbio logo

Aegirbio

aegirbio.com

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Quantitative Insights logo

Quantitative Insights

Attometrics logo

Attometrics

Ahead Project logo

Ahead Project

Accelevir Diagnostics logo

Accelevir Diagnostics

Probius logo

Probius

probius.bio

Test Diagnostics logo

Test Diagnostics

Aqtual - Quick Facts

Who are Aqtual's competitors?

Companies similar to Aqtual include AQH, Exactus, Ariel Precision Medicine and AIQ Solutions.

When was Aqtual founded?

Aqtual was founded in 2018.

Where is Aqtual's headquarters located?

Aqtual's headquarters is located in Hayward, CA, US.

When was Aqtual's last funding round?

Aqtual's most recent funding round was for $16M (USD) in October 2023.

How much has Aqtual raised to-date?

As of Oct 31, 2023, Aqtual has raised a total of $16M (USD).

How many employees does Aqtual have?

Aqtual has 30 employees as of Feb 4, 2024.

Aqtual - Classification

Ownership
  • Private
Technology
  • Biotech
  • Data
Model
  • Platform
Revenue
  • Software
Main Product
  • Diagnostics
  • Healthcare
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software